News/ News/ News/ Oncology/ R&D RhoVac pummelled as lead cancer vaccine fails study Phil Taylor cancer vaccine, immuno-oncology, metastatic, Oncology, Prostate cancer, RhoVac 0 Comment Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase Share X RhoVac pummelled as lead cancer vaccine fails study https://pharmaphorum.com/news/rhovac-pummelled-as-lead-cancer-vaccine-fails-study/
cancer vaccine, immuno-oncology, metastatic, Oncology, Prostate cancer, RhoVac
0 Comment
